Isolated limb perfusion in locally advanced cutaneous melanoma
- 1 August 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (4) , 400-409
- https://doi.org/10.1053/sonc.2002.34119
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Hyperthermic regional perfusion for melanoma and sarcoma of the limbsCurrent Problems in Surgery, 1999
- Isolated limb infusion with cytotoxic agents: A simple alternative to isolated limb perfusionSeminars in Surgical Oncology, 1998
- Melphalan dosing regimens for management of recurrent melanoma by isolated limb perfusion: application of a physiological pharmacokinetic model based on melphalan distribution in the isolated perfused rat hindlimbMelanoma Research, 1997
- Systemic toxicity after isolated limb perfusion with melphalan for melanomaEuropean Journal of Surgical Oncology, 1996
- Pharmacokinetics and results of dose escalation inCis-platin hyperthermic isolation limb perfusionAnnals of Surgical Oncology, 1994
- Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremitiesBritish Journal of Cancer, 1992
- Pharmacokinetics of doxorubicin in man: dose and schedule dependenceZeitschrift für Krebsforschung und Klinische Onkologie, 1988
- Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremitiesThe American Journal of Surgery, 1988
- Selective heat sensitivity of cancer cells. Biochemical and clinical studiesCancer, 1967
- Chemotherapy of CancerAnnals of Surgery, 1958